Lori Anne Kunkel, Director at Loxo Oncology, Inc. (LOXO), sold 5,000 shares at $170.20 ($852K) on 2018-10-01, disclosed to the SEC on 2018-10-03.
Open-market sale of $852k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $170.20 | 4,500 | $766K | 89.9% |
| 2 | $171.90 | 500 | $86K | 10.1% |
| Total | $170.37 avg | 5,000 | $852K | 100% |
| Filing → |
| CRIS | SELL | 2019-01-25 | $16K | — | Filing → |
| LOXO | SELL | 2018-06-18 | $14.1M | — | Filing → |
| LOXO | SELL | 2018-04-24 | $782K | — | Filing → |